Exploring the Mechanical Perspective of a New Anti-Tumor Agent: Melatonin-Reference-Cited by-同舟云学术

Exploring the Mechanical Perspective of a New Anti-Tumor Agent: Melatonin

Published:2023 Issue:1 Volume:42 Page:1-16
ISSN:0731-8898
Container-title:Journal of Environmental Pathology, Toxicology and Oncology
language:en
Short-container-title:J Environ Pathol Toxicol Oncol

Author:

Rohilla Suman,Singh Mahaveer,Priya Sakshi,Almalki Waleed Hassan,Haniffa Shahril Mohamed,Subramaniyan Vetriselvan,Fuloria Shivkanya,Fuloria Neeraj Kumar,Sekar Mahendran,Singh Sachin Kumar,Jha Niraj Kumar,Chellappan Dinesh Kumar,Negi Poonam,Dua Kamal,Gupta Gaurav

Publisher

Begell House

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine,Pathology and Forensic Medicine

Link

https://www.dl.begellhouse.com/download/article/2728a4b80cba7084/JEP(T)-42088.pdf

Reference120 articles.

1. Abrial C, Kwiatkowski F, Chevrier R, Gachon F, Cure H, Chollet P. Therapeutic potential of melatonin in cancer treatment. Pathol Biol. 2005;53(5):265-8.

2. Amin N, Shafabakhsh R, Reiter RJ, Asemi Z. Melatonin is an appropriate candidate for breast cancer treatment: Based on known molecular mechanisms. J Cell Biochem. 2019;120(8):12208-15.

3. Asghari MH, Ghobadi E, Moloudizargari M, Fallah M, Abdollahi M. Does the use of Melatonin overcome drug resistance in cancer chemotherapy? Life Sci. 2018;196:143-55.

4. Asghari MH, Moloudizargari M, Ghobadi E, Fallah M, Abdollahi M. Melatonin as a multifunctional anticancer molecule: Implications in gastric cancer. Life Sci. 2017;185:38-45.

5. Bartsch C, Bartsch H. Melatonin in cancer patients and in tumor-bearing animals. Adv Exp Med Biol. 1999;467:247-64.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long non-coding RNA HOTAIR: A biomarker and therapeutic target in urological tumors;Pathology - Research and Practice;2024-10

2. Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy;Biologics: Targets and Therapy;2024-09

3. Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-21

4. GAS5 lncRNA: A biomarker and therapeutic target in breast cancer;Pathology - Research and Practice;2024-08

5. Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics;Pathology - Research and Practice;2024-07